Class information for:
Level 1: ENDOSIALIN//CD248//ENDOTHELIAL LIKE DIFFERENTIATION

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
26911 242 41.0 88%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
518 3       ANGIOGENESIS//RETINOPATHY OF PREMATURITY//ENDOSTATIN 20826
361 2             ANGIOGENESIS//ENDOSTATIN//VEGF 17372
26911 1                   ENDOSIALIN//CD248//ENDOTHELIAL LIKE DIFFERENTIATION 242

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ENDOSIALIN authKW 3713751 14% 89% 33
2 CD248 authKW 1794544 7% 89% 16
3 ENDOTHELIAL LIKE DIFFERENTIATION authKW 630895 2% 100% 5
4 TEM7 authKW 630895 2% 100% 5
5 TEM1 authKW 621183 3% 62% 8
6 TUMOR ENDOTHELIAL MARKER authKW 454240 2% 60% 6
7 ANTIANGIOGENIC CANCER VACCINE authKW 378537 1% 100% 3
8 MORAB 004 authKW 378537 1% 100% 3
9 ONTUXIZUMAB authKW 378537 1% 100% 3
10 CELL PROTEOMIC FOOTPRINTING authKW 252358 1% 100% 2

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 1548 42% 0% 101
2 Immunology 381 20% 0% 49
3 Medicine, Research & Experimental 363 15% 0% 37
4 Cell Biology 73 11% 0% 26
5 Genetics & Heredity 38 7% 0% 16
6 Biotechnology & Applied Microbiology 20 5% 0% 13
7 Pathology 14 3% 0% 7
8 Biochemistry & Molecular Biology 12 11% 0% 26
9 Hematology 11 3% 0% 7
10 Developmental Biology 10 2% 0% 4

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ANGIOGENESIS BIOMED CANC SCI 126179 0% 100% 1
2 ANGIOGENESIS BIOMED IMMUN INFE 126179 0% 100% 1
3 CANC BIOTHER Y ONCOL 126179 0% 100% 1
4 CANC KASHIWA 126179 0% 100% 1
5 CANCER IMMUNOTHER Y 126179 0% 100% 1
6 CLIN ONCOL UNIT CLIN ONCOL 126179 0% 100% 1
7 GEN SURGSECT 3 126179 0% 100% 1
8 GENOM GRP PROTE 126179 0% 100% 1
9 IMMUN INFECT BIOMED CLIN EXP 126179 0% 100% 1
10 IMMUN INFECT BIOMED MED DEN 126179 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CANCER IMMUNOLOGY IMMUNOTHERAPY 1414 3% 0% 7
2 JOURNAL OF IMMUNOTHERAPY 1194 2% 0% 4
3 GENE EXPRESSION PATTERNS 1135 1% 0% 3
4 JOURNAL OF TRANSLATIONAL MEDICINE 866 2% 0% 4
5 INTERNATIONAL JOURNAL OF ONCOLOGY 837 3% 0% 8
6 VACCINE 685 4% 0% 10
7 HUMAN VACCINES & IMMUNOTHERAPEUTICS 668 1% 0% 3
8 AUTOMATION AND REMOTE CONTROL 531 2% 0% 4
9 ONCOTARGET 494 3% 0% 7
10 BMC CANCER 428 2% 0% 5

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 ENDOSIALIN 3713751 14% 89% 33 Search ENDOSIALIN Search ENDOSIALIN
2 CD248 1794544 7% 89% 16 Search CD248 Search CD248
3 ENDOTHELIAL LIKE DIFFERENTIATION 630895 2% 100% 5 Search ENDOTHELIAL+LIKE+DIFFERENTIATION Search ENDOTHELIAL+LIKE+DIFFERENTIATION
4 TEM7 630895 2% 100% 5 Search TEM7 Search TEM7
5 TEM1 621183 3% 62% 8 Search TEM1 Search TEM1
6 TUMOR ENDOTHELIAL MARKER 454240 2% 60% 6 Search TUMOR+ENDOTHELIAL+MARKER Search TUMOR+ENDOTHELIAL+MARKER
7 ANTIANGIOGENIC CANCER VACCINE 378537 1% 100% 3 Search ANTIANGIOGENIC+CANCER+VACCINE Search ANTIANGIOGENIC+CANCER+VACCINE
8 MORAB 004 378537 1% 100% 3 Search MORAB+004 Search MORAB+004
9 ONTUXIZUMAB 378537 1% 100% 3 Search ONTUXIZUMAB Search ONTUXIZUMAB
10 CELL PROTEOMIC FOOTPRINTING 252358 1% 100% 2 Search CELL+PROTEOMIC+FOOTPRINTING Search CELL+PROTEOMIC+FOOTPRINTING

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 VALDEZ, Y , MAIA, M , CONWAY, EM , (2012) CD248: REVIEWING ITS ROLE IN HEALTH AND DISEASE.CURRENT DRUG TARGETS. VOL. 13. ISSUE 3. P. 432-439 33 61% 10
2 O'SHANNESSY, DJ , SMITH, MF , SOMERS, EB , JACKSON, SM , ALBONE, E , TOMKOWICZ, B , CHENG, X , PARK, Y , FERNANDO, D , MILINICHIK, A , ET AL (2016) NOVEL ANTIBODY PROBES FOR THE CHARACTERIZATION OF ENDOSIALIN/TEM-1.ONCOTARGET. VOL. 7. ISSUE 43. P. 69420 -69435 27 66% 0
3 KONTSEKOVA, S , POLCICOVA, K , TAKACOVA, M , PASTOREKOVA, S , (2016) ENDOSIALIN: MOLECULAR AND FUNCTIONAL LINKS TO TUMOR ANGIOGENESIS.NEOPLASMA. VOL. 63. ISSUE 2. P. 183 -192 29 60% 0
4 CHACKO, AM , LI, CS , NAYAK, M , MIKITSH, JL , HU, J , HOU, C , GRASSO, L , NICOLAIDES, NC , MUZYKANTOV, VR , DIVGI, CR , ET AL (2014) DEVELOPMENT OF I-124 IMMUNO-PET TARGETING TUMOR VASCULAR TEM1/ENDOSIALIN.JOURNAL OF NUCLEAR MEDICINE. VOL. 55. ISSUE 3. P. 500-507 22 69% 9
5 VISKI, C , KONIG, C , KIJEWSKA, M , MOGLER, C , ISACKE, CM , AUGUSTIN, HG , (2016) ENDOSIALIN-EXPRESSING PERICYTES PROMOTE METASTATIC DISSEMINATION.CANCER RESEARCH. VOL. 76. ISSUE 18. P. 5313 -5325 24 51% 1
6 BABU, SS , VALDEZ, Y , XU, A , O'BYRNE, AM , CALVO, F , LEI, V , CONWAY, EM , (2014) TGF BETA-MEDIATED SUPPRESSION OF CD248 IN NON-CANCER CELLS VIA CANONICAL SMAD-DEPENDENT SIGNALING PATHWAYS IS UNCOUPLED IN CANCER CELLS.BMC CANCER. VOL. 14. ISSUE . P. - 27 50% 1
7 THWAY, K , ROBERTSON, D , JONES, RL , SELFE, J , SHIPLEY, J , FISHER, C , ISACKE, CM , (2016) ENDOSIALIN EXPRESSION IN SOFT TISSUE SARCOMA AS A POTENTIAL MARKER OF UNDIFFERENTIATED MESENCHYMAL CELLS.BRITISH JOURNAL OF CANCER. VOL. 115. ISSUE 4. P. 473 -479 16 80% 0
8 HARDIE, DL , BALDWIN, MJ , NAYLOR, A , HAWORTH, OJ , HOU, TZ , LAX, S , CURNOW, SJ , WILLCOX, N , MACFADYEN, J , ISACKE, CM , ET AL (2011) THE STROMAL CELL ANTIGEN CD248 (ENDOSIALIN) IS EXPRESSED ON NAIVE CD8+HUMAN T CELLS AND REGULATES PROLIFERATION.IMMUNOLOGY. VOL. 133. ISSUE 3. P. 288 -295 20 67% 11
9 TOBIAS, A , AGULNIK, M , (2016) ONTUXIZUMAB ANTI-ENDOSIALIN (TEM-1) MONOCLONAL ANTIBODY TREATMENT OF SARCOMA.DRUGS OF THE FUTURE. VOL. 41. ISSUE 8. P. 471 -476 16 76% 0
10 LANGE, SES , ZHELEZNYAK, A , STUDER, M , O'SHANNESSY, DJ , LAPI, SE , VAN TINE, BA , (2016) DEVELOPMENT OF ZR-89-ONTUXIZUMAB FOR IN VIVO TEM-1/ENDOSIALIN PET APPLICATIONS.ONCOTARGET. VOL. 7. ISSUE 11. P. 13082 -13092 17 59% 2

Classes with closest relation at Level 1


Rank Class id link
1 34019 ANGINEX//ENDOTOXIN NEUTRALIZING//TUMOR ANGIOGENESIS
2 19370 VASCULOGENIC MIMICRY//TIANJIN CANC HOSP//TUMOR ENDOTHELIAL CELLS
3 24888 CANC VACCINE DEV//INNOVAT CANC THER Y//PERSONALIZED PEPTIDE VACCINE
4 31640 ANGIOTENSIN II VACCINE//EA4222//KINOID
5 12368 PERICYTES//ADVENTITIAL CELL//LARGE SCALE FUNCT BIOL LLSFBIO
6 1475 VEGF//FLT 1//VEGF RECEPTORS
7 14371 ENDOGLIN//CD105//TRC105
8 16780 CANC VACCINE DEV PROGRAM//CANC IMMUNOL IMMUNOTHER Y//TUMOR VACCINE GRP
9 5798 ENDOSTATIN//ANGIOSTATIN//COLLAGEN XVIII
10 25112 GV1001//PA MSHA VACCINE//HTERTC27

Go to start page